Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy
暂无分享,去创建一个
Eric E. Schadt | Boris Reva | Charles Ascher-Walsh | Timothy T. Harkins | Robert Sebra | E. Schadt | B. Reva | R. Sebra | T. Harkins | P. Dottino | J. Martignetti | S. Tomita | V. Kolev | Samantha Cohen | John A. Martignetti | Deep Pandya | Nimesh Nagarsheth | Ying Chen | Olga Camacho | Shannon Tomita | Michael Brodman | Valentin Kolev | Samantha Cohen | Peter Dottino | M. Brodman | Deep Pandya | C. Ascher-Walsh | N. Nagarsheth | O. Camacho | Ying Chen
[1] Amy Brock,et al. Precision Oncology: Between Vaguely Right and Precisely Wrong. , 2017, Cancer research.
[2] Elena Pereira,et al. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers , 2015, PloS one.
[3] L. Wood,et al. Cancer‐Associated Mutations in Endometriosis without Cancer , 2017, The New England journal of medicine.
[4] E. Topol,et al. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing. , 2018, Clinical chemistry.
[5] J. Garber,et al. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies. , 2015, JAMA.
[6] L. Mcgowan,et al. Cytologic methods for the detection of endometrial cancer. , 1974, Gynecologic oncology.
[7] Quynh-Thu Le,et al. Future cancer research priorities in the USA: a Lancet Oncology Commission. , 2017, The Lancet. Oncology.
[8] M. Choti,et al. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.
[9] B. Reva,et al. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study , 2016, PLoS medicine.
[10] Patrick Neven,et al. Endometrial cancer. , 2005, Lancet.
[11] J. Moore,et al. Endometrial lavage as an aid in the diagnosis of carcinoma of the endometrium. , 1957, Western journal of surgery, obstetrics, and gynecology.
[12] Jorge S. Reis-Filho,et al. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer , 2015, Science Translational Medicine.
[13] S. Lippman,et al. The Conundrum of Genetic “Drivers” in Benign Conditions , 2016, Journal of the National Cancer Institute.
[14] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[15] K. Kinzler,et al. Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] G. Papanicolaou,et al. Cancer of the Uterus: The Vaginal Smear in Its Diagnosis. , 1943, California and western medicine.
[17] A. Shilatifard,et al. Precancer Atlas to Drive Precision Prevention Trials. , 2017, Cancer research.
[18] S. Bandyopadhyay,et al. Endometrial Carcinoma: Precursor Lesions and Molecular Profiles , 2017 .
[19] D. Neuberg,et al. Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues. , 2014, Cancer research.
[20] Bert Vogelstein,et al. DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES , 2014 .
[21] P. Neven,et al. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing. , 2015, JAMA oncology.
[22] Sam Angiuoli,et al. Direct detection of early-stage cancers using circulating tumor DNA , 2017, Science Translational Medicine.
[23] C. Eng,et al. Molecular identification of latent precancers in histologically normal endometrium. , 2001, Cancer research.
[24] James D. Brenton,et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA , 2017, Nature Reviews Cancer.
[25] G. Getz,et al. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis , 2016, Nature Genetics.
[26] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[27] R. Strausberg,et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer , 2016, Science Translational Medicine.
[28] M. Ahn,et al. Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer , 2017, The New England journal of medicine.
[29] M. Ychou,et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts , 2010, Nucleic acids research.
[30] R. Hruban,et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. , 1994, Cancer research.
[31] A. King,et al. Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer , 2017, The New England journal of medicine.
[32] E. Chapman-Davis,et al. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. , 2014, Gynecologic oncology.